[Interferons and nucleoside analogs. New perspectives in therapy of chronic viral hepatitis].
Hinrichsen
H
H
I. Medizinische Klinik, Christian-Albrechts-Universität, Kiel.
Schmidt
W E
WE
D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use*; D019694:Hepatitis B, Chronic / Q000628:therapy*; D019698:Hepatitis C, Chronic / Q000628:therapy*; D019701:Hepatitis D, Chronic / Q000628:therapy*; D006801:Humans; D007372:Interferons / Q000009:adverse effects / Q000627:therapeutic use*; D009705:Nucleosides / Q000009:adverse effects / Q000627:therapeutic use*; D011355:Prodrugs / Q000009:adverse effects / Q000627:therapeutic use; D011379:Prognosis; D016896:Treatment Outcome
D000998:Antiviral Agents; D009705:Nucleosides; D011355:Prodrugs; D007372:Interferons
Interferone und Nukleosidanaloga. Neue Perspektiven in der Therapie chronischer Virushepatitiden.